Spyre Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -3.61%
- Market cap
- $9.77B
- 94.97M shares
- Filings
- 823
FY 2025
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2024derivedN/M FY24 yoy
Q3 2026N/M FY23 yoy
Q3 2026−4.1% FY25 yoy
- $9.77B
- —
- —
- 9.3×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | reported | |
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $886,000 | reported | |
| FY 2022 | 2022-12-31 | $2,329,000 | reported | |
| FY 2021 | 2021-12-31 | $18,739,000 | reported | |
| FY 2020 | 2020-12-31 | $0 | reported | |
| FY 2019 | 2019-12-31 | $0 | reported | |
| FY 2018 | 2018-12-31 | $3,888,000 | reported | |
| FY 2017 | 2017-12-31 | $5,205,000 | reported | |
| FY 2016 | 2016-12-31 | $4,628,000 | reported |
Segments
Products
LineFY2025ShareChange
Development fee and royalty$0.00——
Development Fee———
License———
Total$0.00
Pharmaceutical preparations
Spyre Therapeutics, Inc. is the 32nd largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
SMMTSummit Therapeutics Inc.———$12.1BBMRNBioMarin Pharmaceutical Inc$3.2B12.9%10.8%$11.0BMDGLMadrigal Pharmaceuticals, Inc.$958.4M432.1%30.1%$9.9B
SYRESpyre Therapeutics, Inc. (this company)$0.0——$9.8B
TGTXTG Therapeutics, Inc.$616.3M87.3%72.6%$9.8BPRAXPraxis Precision Medicines, Inc.$0.0100.0%—$9.1BPTGXProtagonist Therapeutics, Inc$46.0M89.4%282.8%$8.8BCORTCorcept Therapeutics Inc$761.4M12.8%13.1%$8.1BALKSAlkermes plc.$1.5B5.2%16.4%$7.9BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Spyre Therapeutics, Inc. · CIK 1636282 · Engraved from SEC EDGAR